Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 328

1.

Treatment for premenstrual syndrome with Vitex agnus castus: A prospective, randomized, multi-center placebo controlled study in China.

He Z, Chen R, Zhou Y, Geng L, Zhang Z, Chen S, Yao Y, Lu J, Lin S.

Maturitas. 2009 May 20;63(1):99-103. doi: 10.1016/j.maturitas.2009.01.006. Epub 2009 Mar 9.

PMID:
19269753
2.

Treatment of moderate to severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women.

Ma L, Lin S, Chen R, Wang X.

Gynecol Endocrinol. 2010 Aug;26(8):612-6. doi: 10.3109/09513591003632126.

PMID:
20334585
3.

Evaluating therapeutic effect in symptoms of moderate-to-severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women.

Ma L, Lin S, Chen R, Zhang Y, Chen F, Wang X.

Aust N Z J Obstet Gynaecol. 2010 Apr;50(2):189-93. doi: 10.1111/j.1479-828X.2010.01137.x.

PMID:
20522079
4.

Efficacy of Vitex agnus castus L. extract Ze 440 in patients with pre-menstrual syndrome (PMS).

Berger D, Schaffner W, Schrader E, Meier B, Brattström A.

Arch Gynecol Obstet. 2000 Nov;264(3):150-3.

PMID:
11129515
5.

Therapeutic effect of Vitex agnus castus in patients with premenstrual syndrome.

Zamani M, Neghab N, Torabian S.

Acta Med Iran. 2012;50(2):101-6.

6.

Dose-dependent efficacy of the Vitex agnus castus extract Ze 440 in patients suffering from premenstrual syndrome.

Schellenberg R, Zimmermann C, Drewe J, Hoexter G, Zahner C.

Phytomedicine. 2012 Nov 15;19(14):1325-31. doi: 10.1016/j.phymed.2012.08.006. Epub 2012 Sep 28.

PMID:
23022391
7.

A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive.

Graham CA, Sherwin BB.

J Psychosom Res. 1992 Apr;36(3):257-66.

PMID:
1564678
8.

[Psychic aspects of the premenstrual dysphoric disorders. New therapeutic strategies: our experience with Vitex agnus castus].

Ciotta L, Pagano I, Stracquadanio M, Di Leo S, Andò A, Formuso C.

Minerva Ginecol. 2011 Jun;63(3):237-45. Italian.

PMID:
21654609
9.

Hypericum perforatum with Vitex agnus-castus in menopausal symptoms: a randomized, controlled trial.

van Die MD, Burger HG, Bone KM, Cohen MM, Teede HJ.

Menopause. 2009 Jan-Feb;16(1):156-63. doi: 10.1097/gme.0b013e31817fa9e0.

PMID:
18791483
10.

Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group.

Thys-Jacobs S, Starkey P, Bernstein D, Tian J.

Am J Obstet Gynecol. 1998 Aug;179(2):444-52.

PMID:
9731851
11.

The efficacy of Femal in women with premenstrual syndrome: a randomised, double-blind, parallel-group, placebo-controlled, multicentre study.

Gerhardsen G, Hansen AV, Killi M, Fornitz GG, Pedersen F, Roos SB.

Adv Ther. 2008 Jun;25(6):595-607. doi: 10.1007/s12325-008-0072-4.

PMID:
18568441
12.
13.

Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder.

Atmaca M, Kumru S, Tezcan E.

Hum Psychopharmacol. 2003 Apr;18(3):191-5.

PMID:
12672170
14.
16.

[Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study].

Milewicz A, Gejdel E, Sworen H, Sienkiewicz K, Jedrzejak J, Teucher T, Schmitz H.

Arzneimittelforschung. 1993 Jul;43(7):752-6. German.

PMID:
8369008
17.
18.

[The premenstrual syndrome: effectiveness of Vitex agnus castus].

Döll M.

Med Monatsschr Pharm. 2009 May;32(5):186-91. Review. German.

PMID:
19469189
19.
20.

Efficacy and safety of Vitex agnus-castus extract for treatment of premenstrual syndrome in Japanese patients: a prospective, open-label study.

Momoeda M, Sasaki H, Tagashira E, Ogishima M, Takano Y, Ochiai K.

Adv Ther. 2014 Mar;31(3):362-73. doi: 10.1007/s12325-014-0106-z. Epub 2014 Mar 7.

PMID:
24604699

Supplemental Content

Support Center